Tag: Ixekizumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Ixekizumab

Avillion/Merck psoriasis nanobody hits the mark in phase 2

Added to Collection on: 2021-04-26 08:26:15

Tags for this article:

Monoclonal antibodies
Immunosuppressants
Medical specialties
Immunology
Drugs
Tildrakizumab
Secukinumab
Psoriasis
Ixekizumab
Bimekizumab
Guselkumab
Risankizumab
IL17A

Click the tags to see associated articles and topics

View Article Details
Stopping IL-17 Drug for Axial Spondyloarthritis? Expect Spinal Flares

Added to Collection on: 2021-05-11 15:56:15

Tags for this article:

Medical specialties
Drugs
Monoclonal antibodies
Clinical medicine
Immunosuppressants
Biotechnology
Clinical research
TNF inhibitors
Ixekizumab
Placebo
Certolizumab pegol
Axial spondyloarthritis

Click the tags to see associated articles and topics

View Article Details
Does Psoriasis Spread? Here's What You Need to Know

Added to Collection on: 2021-08-09 19:30:00

Tags for this article:

Clinical medicine
Medical specialties
Medicine
Psoriasis
Monoclonal antibodies
Immunosuppressants
Autoimmune diseases
Ultraviolet radiation
Ixekizumab
Light therapy
PUVA therapy
Risankizumab

Click the tags to see associated articles and topics

View Article Details
Axial Spondyloarthritis Drugs Market to See Stunning Growth | AstraZeneca Plc, Eli Lilly and ...

Added to Collection on: 2022-02-28 07:24:44

Tags for this article:

Life Sciences
Drugs
Health care
Immunosuppressants
Monoclonal antibodies
Arthritis
Biotechnology
Axial spondyloarthritis
Ixekizumab
Certolizumab pegol
Market research
Novartis

Click the tags to see associated articles and topics

View Article Details
Axial Spondyloarthritis Drugs Market Statistical Forecast, Trade Analysis 2022 - ManufactureLink

Added to Collection on: 2022-05-14 10:59:15

Tags for this article:

Drugs
Immunosuppressants
Monoclonal antibodies
Business process
Organ systems
Medical specialties
Arthritis
Axial spondyloarthritis
Spondyloarthropathy
Certolizumab pegol
Ixekizumab
Market analysis

Click the tags to see associated articles and topics

View Article Details
Women Report Greater Psoriasis QOL Impact, Reduced Treatment Satisfaction With Biologics

Added to Collection on: 2022-06-06 17:00:42

Tags for this article:

Organ systems
Medical specialties
Life Sciences
Immunosuppressants
Monoclonal antibodies
Psoriasis
Autoimmune diseases
Dermatology Life Quality Index
Biopharmaceutical
Ixekizumab
Ustekinumab
Italy

Click the tags to see associated articles and topics

View Article Details
Eli Lilly and Company (LLY) intends to increase sales of immunological illness medications

Added to Collection on: 2022-06-22 12:01:59

Tags for this article:

Life Sciences
Eli Lilly and Company
Monoclonal antibodies
LLY
Ixekizumab
Eli Lilly
Janus kinase inhibitor
Health care
Economy of the United States
Olumiant

Click the tags to see associated articles and topics

View Article Details
Axial Spondyloarthritis Drugs Market Size, Geography Trends, Growth and Forecasts 2028

Added to Collection on: 2022-06-29 12:28:33

Tags for this article:

Life Sciences
Drugs
Health care
Immunosuppressants
Monoclonal antibodies
Axial spondyloarthritis
Arthritis
Certolizumab pegol
Ixekizumab
Novartis
Spondyloarthropathy
Panacea Biotec
Lilly

Click the tags to see associated articles and topics

View Article Details
Study Highlights Real-World Experiences of Psoriasis Patients with Bimekizumab - HCPLive

Added to Collection on: 2024-06-29 19:57:50

Tags for this article:

Monoclonal antibodies
Psoriasis
Autoimmune diseases
Immunosuppressants
Bimekizumab
Interleukin-17A
Biopharmaceutical
Ixekizumab
Interleukin 17F
Psoriatic arthritis
Brodalumab
Dermatology Life Quality Index

Click the tags to see associated articles and topics

View Article Details
Axial Spondyloarthritis Market on Track for Major Expansion by 2034, According to DelveInsight

Added to Collection on: 2024-10-23 15:17:12

Tags for this article:

Monoclonal antibodies
Arthritis
Disease-modifying antirheumatic drugs
Biotechnology
Immunosuppressants
Spondyloarthritis
Certolizumab pegol
Axial spondyloarthritis
Bimekizumab
Ankylosing spondylitis
Biopharmaceutical
Ixekizumab
Eli Lilly and Company
Janssen Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details